Trials / Completed
CompletedNCT02960919
Innovative Treatments in Pneumonia (ITIP) 3
Prospective, Observational Study of Clinical Outcomes Among Children 2 to 59 Months of Age With Childhood Pneumonia and Other Co-morbidities in Lilongwe, Malawi Who Have Been Excluded From Pneumonia Clinical Trials
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,001 (actual)
- Sponsor
- Save the Children · Academic / Other
- Sex
- All
- Age
- 2 Months – 59 Months
- Healthy volunteers
- Not accepted
Summary
This is a prospective observational study assessing the clinical outcomes of children 2 to 59 months of age with both pneumonia and other co-morbidities presenting to a tertiary hospital outpatient setting in Malawi, Africa who are most at risk for mortality or have other complications and thus, are typically excluded from childhood pneumonia studies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | oral amoxicillin or parenteral ampicillin/ penicillin and gentamicin | |
| DRUG | parenteral ampicillin/ penicillin | |
| DRUG | gentamicin |
Timeline
- Start date
- 2016-10-19
- Primary completion
- 2018-06-01
- Completion
- 2018-07-01
- First posted
- 2016-11-10
- Last updated
- 2021-02-21
Locations
2 sites across 1 country: Malawi
Source: ClinicalTrials.gov record NCT02960919. Inclusion in this directory is not an endorsement.